Long-term treatment persistence and maintained reduction of LDL-cholesterol levels with evolocumab over 30 months: Results from the Spanish cohort of the European prospective HEYMANS study

Agustín Blanco Echevarría; Juan de Dios García Díaz; Maria Assumpta Caixas Pedragos; Núria Plana Gil; Miguel Angel Rico Corral; Ian Bridges; Nafeesa Dhalwani; Sònia Gatell Menchén; Kausik K. Ray

Long-term treatment persistence and maintained reduction of LDL-cholesterol levels with evolocumab over 30 months: Results from the Spanish cohort of the European prospective HEYMANS study

Agustín Blanco Echevarría, Juan de Dios García Díaz, Maria Assumpta Caixas Pedragos, Núria Plana Gil, Miguel Angel Rico Corral, Ian Bridges, Nafeesa Dhalwani, Sònia Gatell Menchén, Kausik K. Ray

Department of Medicine

Research output: Contribution to journal › Article › Research › peer-review

3 Citations (Scopus)

Original language	English
Pages (from-to)	263-271
Number of pages	8
Journal	Clínica e investigación en arteriosclerosis
Volume	35
Issue number	6
Publication status	Published - 2023

Cite this

Blanco Echevarría, A., García Díaz, J. D. D., Caixas Pedragos, M. A., Plana Gil, N., Rico Corral, M. A., Bridges, I., Dhalwani, N., Gatell Menchén, S., & K. Ray, K. (2023). Long-term treatment persistence and maintained reduction of LDL-cholesterol levels with evolocumab over 30 months: Results from the Spanish cohort of the European prospective HEYMANS study. Clínica e investigación en arteriosclerosis, 35(6), 263-271.

Blanco Echevarría, Agustín ; García Díaz, Juan de Dios ; Caixas Pedragos, Maria Assumpta et al. / Long-term treatment persistence and maintained reduction of LDL-cholesterol levels with evolocumab over 30 months: Results from the Spanish cohort of the European prospective HEYMANS study. In: Clínica e investigación en arteriosclerosis. 2023 ; Vol. 35, No. 6. pp. 263-271.

@article{c9039d7f28514ab3aaea83fefc3ebca3,

title = "Long-term treatment persistence and maintained reduction of LDL-cholesterol levels with evolocumab over 30 months: Results from the Spanish cohort of the European prospective HEYMANS study",

author = "{Blanco Echevarr{\'i}a}, Agust{\'i}n and {Garc{\'i}a D{\'i}az}, {Juan de Dios} and {Caixas Pedragos}, {Maria Assumpta} and {Plana Gil}, N{\'u}ria and {Rico Corral}, {Miguel Angel} and Ian Bridges and Nafeesa Dhalwani and {Gatell Mench{\'e}n}, S{\`o}nia and {K. Ray}, Kausik",

year = "2023",

language = "English",

volume = "35",

pages = "263--271",

journal = "Cl{\'i}nica e investigaci{\'o}n en arteriosclerosis",

issn = "0214-9168",

publisher = "Elsevier",

number = "6",

}

Blanco Echevarría, A, García Díaz, JDD, Caixas Pedragos, MA, Plana Gil, N, Rico Corral, MA, Bridges, I, Dhalwani, N, Gatell Menchén, S & K. Ray, K 2023, 'Long-term treatment persistence and maintained reduction of LDL-cholesterol levels with evolocumab over 30 months: Results from the Spanish cohort of the European prospective HEYMANS study', Clínica e investigación en arteriosclerosis, vol. 35, no. 6, pp. 263-271.

Long-term treatment persistence and maintained reduction of LDL-cholesterol levels with evolocumab over 30 months: Results from the Spanish cohort of the European prospective HEYMANS study. / Blanco Echevarría, Agustín; García Díaz, Juan de Dios; Caixas Pedragos, Maria Assumpta et al.
In: Clínica e investigación en arteriosclerosis, Vol. 35, No. 6, 2023, p. 263-271.

Research output: Contribution to journal › Article › Research › peer-review

TY - JOUR

T1 - Long-term treatment persistence and maintained reduction of LDL-cholesterol levels with evolocumab over 30 months: Results from the Spanish cohort of the European prospective HEYMANS study

AU - Blanco Echevarría, Agustín

AU - García Díaz, Juan de Dios

AU - Caixas Pedragos, Maria Assumpta

AU - Plana Gil, Núria

AU - Rico Corral, Miguel Angel

AU - Bridges, Ian

AU - Dhalwani, Nafeesa

AU - Gatell Menchén, Sònia

AU - K. Ray, Kausik

PY - 2023

Y1 - 2023

UR - http://dialnet.unirioja.es/servlet/articulo?codigo=9203069

M3 - Article

SN - 0214-9168

VL - 35

SP - 263

EP - 271

JO - Clínica e investigación en arteriosclerosis

JF - Clínica e investigación en arteriosclerosis

IS - 6

ER -

Long-term treatment persistence and maintained reduction of LDL-cholesterol levels with evolocumab over 30 months: Results from the Spanish cohort of the European prospective HEYMANS study

Other files and links

Cite this